XML 21 R10.htm IDEA: XBRL DOCUMENT v3.25.3
Segments
 9 Months Ended
Sep. 30, 2025
Segments [Abstract]  
Segments

3.    Segments

Our segments include the VITAS segment and the Roto-Rooter segment, which comprise the structure used by our President and Chief Executive Officer, who has been determined to be our Chief Operating Decision Maker (“CODM”) to make key operating decisions and assess performance. Relative contributions of each segment to service revenues and sales for the third quarter of 2025 and 2024 were 65% and 35%. Relative contributions of each segment to service revenues and sales for the first nine months of 2025 were 64% and 36% compared to the first nine months of 2024 were 63% and 37%. The vast majority of our service revenues and sales from continuing operations are generated from business within the United States. Service revenues and sales by business segment are shown in Note 2.

The reportable segments have been defined along service lines, which is consistent with the way the businesses are managed. In determining reportable segments, the RRSC and RRC operating units of the Roto-Rooter segment have been aggregated on the basis of possessing similar operating and economic characteristics. The characteristics of these operating segments and the basis for aggregation are reviewed annually.

We report corporate administrative expenses and unallocated investing and financing income and expense not directly related to either segment as “Corporate”. Corporate administrative expense includes the stewardship, accounting and reporting, legal, tax and other costs of operating a publicly held corporation. Corporate investing and financing income and expenses include the costs and income associated with corporate debt and investment arrangements.

Our CODM evaluates the segments’ operating performance based mainly on income/(loss) from operations. For each segment, the CODM compares segment income/(loss) from operations in the annual budgeting and monthly forecasting process to actual results. The CODM considers variances on a monthly basis for evaluating performance of each segment and making decisions about allocating resources to each segment.


‎

Segment data for the three months ending September 30, 2025 are as follows (in thousands):

Reportable

Chemed

VITAS

Roto-Rooter

Segments

Corporate

Consolidated

Service revenues and sales

$

407,741 

$

217,159 

$

624,900 

$

-

$

624,900 

Cost of services provided and goods sold

(excluding depreciation)

Wages

239,357 

72,992 

312,349 

-

312,349 

Patient care expense

43,269 

-

43,269 

-

43,269 

Other expenses

38,239 

34,136 

72,375 

-

72,375 

Total cost of services provided and goods sold

320,865 

107,128 

427,993 

-

427,993 

Selling, general and administrative expense

Wages

16,904 

21,122 

38,026 

6,440 

44,466 

Advertising

-

19,542 

19,542 

-

19,542 

Stock compensation

-

-

-

5,851 

5,851 

Other expenses

8,332 

20,008 

28,340 

7,576 

35,916 

Total selling, general and administrative expense

25,236 

60,672 

85,908 

19,867 

105,775 

Depreciation

5,354 

8,298 

13,652 

12 

13,664 

Amortization

26 

2,544 

2,570 

-

2,570 

Other operating expense/(income)

186 

(38)

148 

-

148 

Total costs and expenses

351,667 

178,604 

530,271 

19,879 

550,150 

Income/(loss) from operations

56,074 

38,555 

94,629 

(19,879)

74,750 

Interest expense

(56)

(132)

(188)

(269)

(457)

Intercompany interest income/(expense)

5,685 

4,030 

9,715 

(9,715)

-

Other income - net

61 

25 

86 

9,165 

9,251 

Income/(expense) before income taxes

61,764 

42,478 

104,242 

(20,698)

83,544 

Income taxes

(14,993)

(10,407)

(25,400)

6,093 

(19,307)

Net income/(loss)

$

46,771 

$

32,071 

$

78,842 

$

(14,605)

$

64,237 

Additions to long-lived assets

$

10,850 

$

6,639 

$

17,489 

$

10 

$

17,499 


‎

Segment data for the three months September 30, 2024 are as follows (in thousands):

Reportable

Chemed

VITAS

Roto-Rooter

Segments

Corporate

Consolidated

Service revenues and sales

$

391,406 

$

214,775 

$

606,181 

$

-

$

606,181 

Cost of services provided and goods sold

(excluding depreciation)

Wages

222,868 

70,078 

292,946 

-

292,946 

Patient care expense

37,188 

-

37,188 

-

37,188 

Other expenses

34,880 

31,173 

66,053 

-

66,053 

Total cost of services provided and good sold

294,936 

101,251 

396,187 

-

396,187 

Selling, general and administrative expense

Wages

17,658 

18,979 

36,637 

3,643 

40,280 

Advertising

-

18,420 

18,420 

-

18,420 

Stock compensation

-

-

-

9,121 

9,121 

Other expenses

8,225 

19,673 

27,898 

6,262 

34,160 

Total selling, general and administrative expense

25,883 

57,072 

82,955 

19,026 

101,981 

Depreciation

5,063 

8,071 

13,134 

13 

13,147 

Amortization

26 

2,524 

2,550 

-

2,550 

Other operating expense/(income)

97 

62 

159 

-

159 

Total costs and expenses

326,005 

168,980 

494,985 

19,039 

514,024 

Income/(loss) from operations

65,401 

45,795 

111,196 

(19,039)

92,157 

Interest expense

(46)

(114)

(160)

(267)

(427)

Intercompany interest income/(expense)

4,920 

3,656 

8,576 

(8,576)

-

Other income - net

62 

18 

80 

9,219 

9,299 

Income/(expense) before income taxes

70,337 

49,355 

119,692 

(18,663)

101,029 

Income taxes

(16,851)

(11,400)

(28,251)

2,998 

(25,253)

Net income/(loss)

$

53,486 

$

37,955 

$

91,441 

$

(15,665)

$

75,776 

Additions to long-lived assets

$

7,768 

$

10,778 

$

18,546 

$

100 

$

18,646 


‎

Segment data for the nine months September 30, 2025 are as follows (in thousands):

Reportable

Chemed

VITAS

Roto-Rooter

Segments

Corporate

Consolidated

Service revenues and sales

$

1,211,341 

$

679,300 

$

1,890,641 

$

-

$

1,890,641 

Cost of services provided and goods sold

(excluding depreciation)

Wages

716,335 

226,168 

942,503 

-

942,503 

Patient care expense

124,656 

-

124,656 

-

124,656 

Other expenses

113,325 

112,144 

225,469 

-

225,469 

Total cost of services provided and goods sold

954,316 

338,312 

1,292,628 

-

1,292,628 

Selling, general and administrative expense

Wages

51,188 

63,326 

114,514 

13,919 

128,433 

Advertising

-

56,654 

56,654 

-

56,654 

Stock compensation

-

-

-

27,668 

27,668 

Other expenses

25,673 

63,876 

89,549 

9,381 

98,930 

Total selling, general and administrative expense

76,861 

183,856 

260,717 

50,968 

311,685 

Depreciation

15,863 

24,899 

40,762 

36 

40,798 

Amortization

78 

7,635 

7,713 

-

7,713 

Other operating expense/(income)

305 

(80)

225 

-

225 

Total costs and expenses

1,047,423 

554,622 

1,602,045 

51,004 

1,653,049 

Income/(loss) from operations

163,918 

124,678 

288,596 

(51,004)

237,592 

Interest expense

(150)

(394)

(544)

(685)

(1,229)

Intercompany interest income/(expense)

16,436 

11,930 

28,366 

(28,366)

-

Other income - net

170 

58 

228 

13,742 

13,970 

Income/(expense) before income taxes

180,374 

136,272 

316,646 

(66,313)

250,333 

Income taxes

(45,353)

(32,344)

(77,697)

15,851 

(61,846)

Net income/(loss)

$

135,021 

$

103,928 

$

238,949 

$

(50,462)

$

188,487 

Additions to long-lived assets

$

22,234 

$

24,825 

$

47,059 

$

15 

$

47,074 


‎

Segment data for the nine months September 30, 2024 are as follows (in thousands):

Reportable

Chemed

VITAS

Roto-Rooter

Segments

Corporate

Consolidated

Service revenues and sales

$

1,119,970 

$

671,324 

$

1,791,294 

$

-

$

1,791,294 

Cost of services provided and goods sold

(excluding depreciation)

Wages

639,103 

221,669 

860,772 

-

860,772 

Patient care expense

108,887 

-

108,887 

-

108,887 

Other expenses

104,357 

97,048 

201,405 

-

201,405 

Total cost of services provided and goods sold

852,347 

318,717 

1,171,064 

-

1,171,064 

Selling, general and administrative expense

Wages

51,556 

60,056 

111,612 

11,950 

123,562 

Advertising

-

55,271 

55,271 

-

55,271 

Stock compensation

-

-

-

39,730 

39,730 

Other expenses

22,412 

60,356 

82,768 

18,778 

101,546 

Total selling, general and administrative expense

73,968 

175,683 

249,651 

70,458 

320,109 

Depreciation

15,288 

24,275 

39,563 

38 

39,601 

Amortization

79 

7,538 

7,617 

-

7,617 

Other operating expense

160 

128 

288 

-

288 

Total costs and expenses

941,842 

526,341 

1,468,183 

70,496 

1,538,679 

Income/(loss) from operations

178,128 

144,983 

323,111 

(70,496)

252,615 

Interest expense

(138)

(349)

(487)

(794)

(1,281)

Intercompany interest income/(expense)

15,096 

10,638 

25,734 

(25,734)

-

Other income - net

138 

64 

202 

27,806 

28,008 

Income/(expense) before income taxes

193,224 

155,336 

348,560 

(69,218)

279,342 

Income taxes

(46,517)

(36,010)

(82,527)

14,865 

(67,662)

Net income/(loss)

$

146,707 

$

119,326 

$

266,033 

$

(54,353)

$

211,680 

Additions to long-lived assets

$

104,337 

$

29,800 

$

134,137 

$

271 

$

134,408 

Identifiable assets by segment are as follows (in thousands):

September 30,

December 31,

2025

2024

VITAS

$

822,484 

$

839,568 

Roto-Rooter

535,182 

529,076 

Reportable segments

1,357,666 

1,368,644 

Corporate

265,953 

299,931 

Chemed consolidated

$

1,623,619 

$

1,668,575